All News Tianda Pharmaceuticals Limited

Equities

455 KYG887471038

Market Closed - Hong Kong S.E. Other stock markets 04:08:42 2024-06-28 EDT			5-day change	1st Jan Change
0.26 ^HKD	0.00%		+1.96%	+19.27%

06-11	Tianda Pharma Unit's Ibuprofen Gets Approval in China	MT
06-11	Tianda Pharmaceutical Technology Co., Ltd. Receives Drug Registration Approval of Ibuprofen Suspension	CI

All News

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Tianda Pharma Unit's Ibuprofen Gets Approval in China	06-11	MT
Tianda Pharmaceutical Technology Co., Ltd. Receives Drug Registration Approval of Ibuprofen Suspension	06-11	CI
Tianda Pharmaceuticals Limited Approves Final Dividend	06-07	CI
Tianda Pharmaceuticals Unit Gets Registration Go-Ahead for Acute Coronary Drug from Chinese Regulator	05-16	MT
Tianda Pharmaceuticals Limited Proposes Final Dividend for the Year Ended 31 December 2023, Payable on 28 June 2024	03-26	CI
Tianda Pharmaceuticals Limited Reports Earnings Results for the Full Year Ended December 31, 2023	03-26	CI
Tianda Pharmaceuticals Limited Provides Consolidated Earnings Guidance for the Current Year from 1 January 2023 to 31 December 2023	03-21	CI
Tianda Pharmaceuticals Limited Announces Executive Changes, Effective 29 August 2023	23-08-28	CI
Tianda Pharmaceuticals Limited Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-28	CI
Tianda Pharmaceuticals to Shrink H1 Loss by Over 70%	23-08-24	MT
Tianda Pharmaceuticals Limited Provides Consolidated Earnings Guidance for the Interim Period Ended June 30, 2023	23-08-23	CI
Tianda Unit Buys Out 45% Stake in Meng Sheng Pharmaceutical	23-08-02	MT
Tianda Pharmaceuticals Limited entered into an equity transfer agreement to acquire 45% stake in Yunnan Mengsheng Pharmaceutical Co., Ltd from Yunnan Linuo Biotechnology Co., Ltd. for HKD 23.5 million.	23-07-31	CI
Tianda Pharmaceuticals Limited Announces Board Changes	23-06-27	CI
Tianda Pharmaceuticals Limited Approves Final Dividend	23-06-27	CI
Tianda Pharmaceuticals Limited Proposes Final Dividend for the Nine Months Ended 31 December 2022, Payable on or Before, 14 July 2023	23-05-19	CI
Tianda Pharmaceuticals Unit to Invest HK$10 Million in Fund	23-04-19	MT
Beijing Tong Ren Tang Chinese Medicine’s CEO Redesignated; New CEO Named	23-04-19	MT
Tianda Pharmaceuticals Limited Announces Final Ordinary Dividend for the Nine Months Ended 31 December 2023	23-03-23	CI
Tianda Pharmaceuticals Limited Reports Earnings Results for the Nine Months Ended December 31, 2022	23-03-23	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

All News Tianda Pharmaceuticals Limited

Equities

455

KYG887471038

All News

Filters